CLK4
Basic information
Region (hg38): 5:178602664-178630615
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLK4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 25 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 1 | 1 |
Variants in CLK4
This is a list of pathogenic ClinVar variants found in the CLK4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-178603622-T-C | not specified | Uncertain significance (Aug 01, 2024) | ||
5-178603657-G-C | not specified | Uncertain significance (Jan 18, 2025) | ||
5-178603705-C-T | not specified | Uncertain significance (Dec 13, 2024) | ||
5-178603741-T-C | not specified | Uncertain significance (Nov 14, 2024) | ||
5-178603753-A-C | not specified | Uncertain significance (May 09, 2023) | ||
5-178603861-G-A | not specified | Uncertain significance (May 07, 2024) | ||
5-178605313-G-C | not specified | Uncertain significance (Dec 06, 2022) | ||
5-178605319-T-A | not specified | Uncertain significance (Feb 12, 2024) | ||
5-178612457-A-G | not specified | Uncertain significance (Jul 05, 2023) | ||
5-178612475-T-C | not specified | Uncertain significance (Sep 08, 2024) | ||
5-178612484-G-A | not specified | Uncertain significance (Sep 27, 2024) | ||
5-178612885-G-A | not specified | Uncertain significance (Jan 05, 2022) | ||
5-178613479-T-C | not specified | Uncertain significance (Jan 22, 2024) | ||
5-178613511-A-T | not specified | Uncertain significance (Jan 24, 2025) | ||
5-178613635-A-G | not specified | Uncertain significance (Sep 30, 2024) | ||
5-178613637-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
5-178613794-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
5-178613815-C-T | not specified | Uncertain significance (Oct 28, 2024) | ||
5-178613836-T-C | not specified | Uncertain significance (Jan 10, 2023) | ||
5-178613841-T-C | not specified | Uncertain significance (Aug 02, 2022) | ||
5-178617352-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
5-178618590-C-T | not specified | Uncertain significance (Dec 12, 2022) | ||
5-178618612-T-C | not specified | Uncertain significance (Jan 27, 2025) | ||
5-178618643-G-A | Benign (Sep 01, 2017) | |||
5-178618723-C-T | not specified | Likely benign (Aug 30, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CLK4 | protein_coding | protein_coding | ENST00000316308 | 12 | 27952 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000619 | 0.999 | 125715 | 0 | 33 | 125748 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.11 | 181 | 280 | 0.645 | 0.0000161 | 3235 |
Missense in Polyphen | 40 | 96.906 | 0.41277 | 1186 | ||
Synonymous | -0.0430 | 90 | 89.5 | 1.01 | 0.00000485 | 807 |
Loss of Function | 2.87 | 12 | 28.6 | 0.420 | 0.00000159 | 346 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000343 | 0.000333 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000109 |
Finnish | 0.0000513 | 0.0000462 |
European (Non-Finnish) | 0.000178 | 0.000176 |
Middle Eastern | 0.000111 | 0.000109 |
South Asian | 0.0000985 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. {ECO:0000269|PubMed:11170754, ECO:0000269|PubMed:19168442}.;
- Pathway
- mRNA Processing
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.581
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.22
Haploinsufficiency Scores
- pHI
- 0.201
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.591
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Clk4
- Phenotype
Gene ontology
- Biological process
- peptidyl-tyrosine phosphorylation;regulation of RNA splicing;protein autophosphorylation
- Cellular component
- nucleus
- Molecular function
- protein serine/threonine kinase activity;protein serine/threonine/tyrosine kinase activity;protein tyrosine kinase activity;protein binding;ATP binding